TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Jonel Pasula Reumatolog AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 32 | 42 | 15 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 23 | -15 | -21 |
EBITDA | 9 | -16 | -21 |
Total assets | 759 | 871 | 1,063 |
Current assets | 760 | 871 | 1,063 |
Current liabilities | 481 | 471 | 634 |
Equity capital | 264 | 382 | 407 |
- share capital | 101 | 95 | 98 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 34.8% | 43.9% | 38.3% |
Turnover per employee | 32 | 42 | 15 |
Profit as a percentage of turnover | 71.9% | -35.7% | -140.0% |
Return on assets (ROA) | 3.0% | -1.7% | -2.0% |
Current ratio | 158.0% | 184.9% | 167.7% |
Return on equity (ROE) | 8.7% | -3.9% | -5.2% |
Change turnover | -12 | 27 | -22 |
Change turnover % | -27% | 193% | -61% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.